Informação sobre produto
- 1-Pyrrolidineacetamide, N-[2-[bis(1-methylethyl)amino]ethyl]-2-oxo-
- Amacetam
- N-[2-(dipropan-2-ylamino)ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide
- N-[2-(dipropan-2-ylamino)ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide sulfate (1:1)
- N-[2-[Bis(1-methylethyl)amino]ethyl]-2-oxo-1-pyrrolidineacetamide
- Vinpotropil
Pramiracetam is a nootropic drug that is used to treat symptoms of dementia and other cognitive disorders. It has pharmacological effects on the brain by interacting with the fatty acid composition of cell membranes, which affects voltage-dependent calcium channels. Pramiracetam also increases cholinergic neurotransmission and increases energy metabolism in cells by increasing adenosine triphosphate (ATP) synthesis. This drug's pharmacokinetic properties include a high bioavailability, rapid absorption, and short half-life. Histological analysis of animals treated with pramiracetam has shown an increase in the size of neurons and synapses in the cerebral cortex, hippocampus, olfactory bulb, cerebellum, and hypothalamus.
Propriedades químicas
Consulta técnica sobre: 3D-FP35140 Pramiracetam
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
